- Hindustan Unilever‘s net income for the fourth quarter was 24.9 billion rupees, marking a 3.3% increase compared to the previous year and aligning with market expectations of 24.87 billion rupees.
- The company recorded revenue of 150.00 billion rupees, showing a 2.1% growth from the previous year, although slightly below the estimated 152.64 billion rupees.
- Total costs rose by 2.8% year-over-year, reaching 121.4 billion rupees.
- The dividend per share declared by Hindustan Unilever was 24 rupees.
- Investor sentiment remains mostly positive with 29 buy recommendations, 12 holds, and 3 sell ratings.
A look at Hindustan Unilever Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 2 | |
| Dividend | 5 | |
| Growth | 3 | |
| Resilience | 5 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Hindustan Unilever‘s long-term outlook appears promising. With a top score in Dividend and Resilience, the company demonstrates strong performance in providing dividends to investors and in weathering market uncertainties. This indicates stability and consistent returns for shareholders.
While the Value score is moderate, suggesting room for improvement in terms of undervaluation, the Growth and Momentum scores indicate a positive upward trajectory in terms of expansion and market performance. With a diversified product portfolio that includes consumer goods and food items, Hindustan Unilever is well-positioned to maintain its strong presence in the global market.
Summary: Hindustan Unilever Limited is a consumer products manufacturer known for its wide range of offerings, including soap, detergent, personal care products, processed food, ice creams, and cooking oils. The company serves customers worldwide and is recognized for its consistent performance and resilience in the market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
